Dexmedetomidine for hip fracture surgery

effect of dexmedetomidine infusion during hip fracture surgery on hemodynamic parameters and blood loss in trauma patients: A randomized triple blinded prospective Trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20191222045857N1

Enrollment

Registered

2020-09-26

Start date

2020-06-25

Completion date

Unknown

Last updated

2020-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip fracture. Displaced intertrochanteric fracture of right femur

Interventions

Intervention 1: Intervention group (Group A): Infusion Dexmedetomidine 0.5 µ/ Kg/h. midazolam (0.03 mg/kg), phentanyl (2microg/kg) and lidocaine 2% (1mg/kg) will be administered as premed to all patie

Eligibility

Sex/Gender

All

Age

30 Years to 70 Years

Inclusion criteria

Inclusion criteria: Age between 30 and 70 years candidate for fixation of a hip fracture ASA class I or II Hemoglobin equal to 10 mg/dL or more

Exclusion criteria

Exclusion criteria: sensitivity to Dexmedetomidine coagulation disorders past surgical history at the same of location uncontrolled high blood pressure

Design outcomes

Primary

Measure	Time frame
Intraoperative bleeding volume. Timepoint: during surgery. Method of measurement: the number of gas consumed and the amount of blood suctioned.;Mean arterial pressure. Timepoint: Every 15 minutes till the end of surgery. Method of measurement: In mmHg with intra arterial manometry.;Heart rate. Timepoint: Every 15 minutes till the end of surgery. Method of measurement: With cardiac monitoring.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFardis Vosoughi

Artesh University of Medical Sciences

fardis.vosoughi@gmail.com+98 21 8827 0873

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 20, 2026